Barbara Maschera

2.0k total citations
20 papers, 1.7k citations indexed

About

Barbara Maschera is a scholar working on Immunology, Epidemiology and Cancer Research. According to data from OpenAlex, Barbara Maschera has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Barbara Maschera's work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and HIV Research and Treatment (4 papers). Barbara Maschera is often cited by papers focused on Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and HIV Research and Treatment (4 papers). Barbara Maschera collaborates with scholars based in United Kingdom, Switzerland and Italy. Barbara Maschera's co-authors include Filippo Volpe, Keith P. Ray, Edward D. Blair, Kimberly Burns, Richard Myers, Margaret Tisdale, Eric S. Furfine, J Tschopp, Alan J. Lewis and Chris Plumpton and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Cell Biology.

In The Last Decade

Barbara Maschera

19 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Maschera United Kingdom 15 606 562 525 492 283 20 1.7k
Elias G. Argyris United States 12 475 0.8× 387 0.7× 749 1.4× 593 1.2× 328 1.2× 19 1.5k
Lu Ding China 25 466 0.8× 327 0.6× 588 1.1× 524 1.1× 298 1.1× 55 1.7k
Silvia Ghezzi Italy 26 727 1.2× 480 0.9× 745 1.4× 359 0.7× 141 0.5× 94 2.2k
Ping An United States 31 636 1.0× 550 1.0× 750 1.4× 701 1.4× 238 0.8× 76 2.5k
Ratan K. Maitra United States 18 391 0.6× 224 0.4× 254 0.5× 995 2.0× 146 0.5× 27 1.6k
A. Benedetto Italy 27 381 0.6× 509 0.9× 524 1.0× 630 1.3× 242 0.9× 94 2.1k
Jeff Skinner United States 25 1.1k 1.8× 331 0.6× 401 0.8× 560 1.1× 61 0.2× 47 2.3k
Lucia Conti Italy 24 1.1k 1.8× 209 0.4× 405 0.8× 401 0.8× 152 0.5× 51 1.8k
Mayte Coiras Spain 24 422 0.7× 739 1.3× 621 1.2× 437 0.9× 63 0.2× 69 1.9k
Gary J. Nabel United States 14 1.1k 1.9× 581 1.0× 645 1.2× 801 1.6× 658 2.3× 18 2.5k

Countries citing papers authored by Barbara Maschera

Since Specialization
Citations

This map shows the geographic impact of Barbara Maschera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Maschera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Maschera more than expected).

Fields of papers citing papers by Barbara Maschera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Maschera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Maschera. The network helps show where Barbara Maschera may publish in the future.

Co-authorship network of co-authors of Barbara Maschera

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Maschera. A scholar is included among the top collaborators of Barbara Maschera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Maschera. Barbara Maschera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lea, Simon, et al.. (2021). Assessment of bacterial exposure on phagocytic capability and surface marker expression of sputum macrophages and neutrophils in COPD patients. Clinical & Experimental Immunology. 206(1). 99–109. 9 indexed citations
2.
Wang, Zhang, Barbara Maschera, Simon Lea, et al.. (2019). Airway host-microbiome interactions in chronic obstructive pulmonary disease. Respiratory Research. 20(1). 113–113. 99 indexed citations
3.
Kolsum, Umme, et al.. (2017). Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK. SHILAP Revista de lepidopterología.
4.
Kolsum, Umme, Barbara Maschera, Karen D. Simpson, et al.. (2017). Ampicillin resistance in <em>Haemophilus influenzae</em> from COPD patients in the UK. International Journal of COPD. Volume 12. 1507–1518. 24 indexed citations
5.
Higham, Andrew, Simon Lea, Jonathan Plumb, et al.. (2013). The role of the liver X receptor in chronic obstructive pulmonary disease. Respiratory Research. 14(1). 106–106. 29 indexed citations
6.
Schaaf, Marcel J. M., et al.. (2006). The Relationship between Intranuclear Mobility of the NF-κB Subunit p65 and Its DNA Binding Affinity. Journal of Biological Chemistry. 281(31). 22409–22420. 22 indexed citations
7.
Garside, Helen, Adam Stevens, Stuart Farrow, et al.. (2004). Glucocorticoid Ligands Specify Different Interactions with NF-κB by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain. Journal of Biological Chemistry. 279(48). 50050–50059. 96 indexed citations
8.
Austin, Richard J., et al.. (2002). Mometasone furoate is a less specific glucocorticoid than fluticasone propionate. European Respiratory Journal. 20(6). 1386–1392. 31 indexed citations
9.
Burns, Kimberly, Laurence Martin, Fabio Martinon, et al.. (2000). Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nature Cell Biology. 2(6). 346–351. 447 indexed citations
10.
Maschera, Barbara, Keith P. Ray, Kimberly Burns, & Filippo Volpe. (1999). Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-κB. Biochemical Journal. 339(2). 227–227. 16 indexed citations
11.
Maschera, Barbara, Keith P. Ray, Kimberly Burns, & Filippo Volpe. (1999). Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB.. PubMed. 339 ( Pt 2). 227–31. 80 indexed citations
12.
Maschera, Barbara, Keith P. Ray, Kimberly Burns, & Filippo Volpe. (1999). Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-κB. Biochemical Journal. 339(2). 227–231. 64 indexed citations
13.
14.
Maschera, Barbara, G. Darby, Giorgio Palù, et al.. (1996). Human Immunodeficiency Virus. Journal of Biological Chemistry. 271(52). 33231–33235. 300 indexed citations
15.
Tisdale, Margaret, et al.. (1995). Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. Antimicrobial Agents and Chemotherapy. 39(8). 1704–1710. 159 indexed citations
16.
Maschera, Barbara, Eric S. Furfine, & Edward D. Blair. (1995). Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors. Journal of Virology. 69(9). 5431–5436. 65 indexed citations
17.
Partaledis, Judith A., Koushi Yamaguchi, Margaret Tisdale, et al.. (1995). In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease. Journal of Virology. 69(9). 5228–5235. 155 indexed citations
18.
Maschera, Barbara, et al.. (1993). Polymerase chain reaction amplification and restriction enzyme typing as an accurate and simple way to detect and identify human papillomaviruses. Journal of Medical Microbiology. 39(1). 33–38. 8 indexed citations
19.
Maschera, Barbara, et al.. (1993). Evaluation of Topoisomerase Inhibitors as Potential Antiviral Agents. Antiviral chemistry & chemotherapy. 4(2). 85–91. 5 indexed citations
20.
Capobianco, Massimo L., Anna Garbesi, F Arcamone, Barbara Maschera, & Giorgio Palù. (1991). Control of the expression of an early gene of SV40 with natural and modified oligonucleotides.. PubMed. 274–274. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elias G. Argyris Breakdown of academic impact, for papers by Lu Ding Breakdown of academic impact, for papers by Silvia Ghezzi Breakdown of academic impact, for papers by Ping An Breakdown of academic impact, for papers by Ratan K. Maitra Breakdown of academic impact, for papers by A. Benedetto Breakdown of academic impact, for papers by Jeff Skinner Breakdown of academic impact, for papers by Lucia Conti Breakdown of academic impact, for papers by Mayte Coiras Breakdown of academic impact, for papers by Gary J. Nabel
Rankless by CCL
2026